Skip Navigation

Adalvo Recognizes Global Pain Awareness Month with Innovative Pain Portfolio

Business
13 September 2023

Adalvo proudly acknowledges September as Pain Awareness Month, joining the global community in raising awareness about the challenges faced by individuals dealing with chronic pain.

With a strong commitment to improving the lives of patients worldwide, Adalvo has made significant strides in the field of pain management, offering innovative solutions that make a meaningful impact.

Adalvo is dedicated to expanding its portfolio and currently provides a comprehensive selection of four distinct dossiers, totaling a global market size of $4.5BN, as reported by IQVIA.

As we recognize Pain Awareness Month, Adalvo reaffirms its commitment to advancing pain management solutions. We believe that every patient deserves access to effective pain relief, and our ongoing research and development efforts reflect this unwavering dedication.

Our pain portfolio is a testament to Adalvo's mission of making a difference in patients' lives. We understand that pain can be a barrier to living life to the fullest, and our innovative products aim to break down that barrier.

Adalvo will continue to grow their portfolio offerings in this domain, further highlighting our ability to offer differentiated, value-added products to our partners.

Partner up now!  

At Adalvo, there are no half measures – we are always on target. When your mission is to be faster and stronger than your competitors, you need a winning team driving your vision forward.

Get in touch with your preferred Business Partner today!

arni.baldursson@adalvo.com - Head of Global BD&L

camila.reinoso@adalvo.com - LATAM (exc. Brazil)

margarida.neves@adalvo.com – Brazil

marta.puig@adalvo.com - South Europe

ajish.rajan@adalvo.com – Central & Eastern Europe, Russia & CIS

jose.rendueles@adalvo.com- North Europe, APAC, MENA & Israel

paulo.rodriguez@adalvo.com – Europe

supreet.sharma@adalvo.com – UK/Ireland, North America & South Africa

Disclaimer: Products which are subject to patent protection are currently not offered or made available in countries where patents are in force.